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Abstract 
Despite intracellular molecular dynamics is fundamental to understand pathological, 
biomechanical or biochemical events, several processes are still not clear because of the 
difficulty of monitoring and measuring these phenomena. To engineer an effective 
fluorescent tool useful to improve protein intracellular tracking studies, we fused a 
supernegative green fluorescent protein, (-30)GFP, to a myogenic transcription factor, MyoD. 
The (-30)GFP-MyoD was able to pass the plasma membrane when complexed with cationic 
lipids. Fluorescence confocal microscopy showed the protein delivery in just 3 hours with 
high levels of protein transduction efficiency. Confocal acquisitions also confirmed the 
maintenance of the MyoD nuclear localization. To examine how the supernegative GFP 
influenced MyoD activity, we did gene expression analyses, which showed an inhibitory 
effect of (-30)GFP on transcription factor function. This negative effect was possibly due to a 
charge-driven interference mechanism, as suggested by further investigations by molecular 
dynamics simulations. Summarizing these results, despite the functional limitations related to 
the charge structural characteristics that specifically affected MyoD function, we found (-
30)GFP is a suitable fluorescent label for improving protein intracellular tracking studies, 
such as nucleocytoplasmic transport in mechanotransduction. 
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1. Introduction 
Optical microscopy has become an integral part of modern 
cell biology, not only thanks to huge advances in spatial 
resolution but above all for the fact that we can now study 
complex systems such as living cells and their dynamics. 
Over the last decades, from the discovery of the green 
fluorescent protein (GFP), extracted from the jellyfish 
Aequorea victoria [1, 2], remarkable advances have been 
made in molecular engineering to generate fluorescent tools 
for studying cell biology and physiology by optical and 
imaging techniques [3]. Beyond the GFP-derived labels, 
fluorophores and nanoparticles serve as alternative labeling 
strategies in cell and molecular visualization approaches [4]. 
Organic fluorophores such as Cy5 and Cy3 offer high 
brightness and small size. Since labeling the protein of 
interest (POI) is mediated by two complementary reactive 
groups – such as the maleimide group of the fluorophore and 
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the cysteine residue of the POI – the main problem with this 
labeling strategy is low specificity. The fusion of protein tags 
(e.g. Halo, SNAP) to bind the fluorophores can increase the 
specificity but it alters the size of the labeling complex, 
nullifying the small dimension-related advantage [5, 6]. 
Quantum dots (Qdot) are nanoparticle labels exploited for 
their brightness and photostability. Their main disadvantage 
is that they have to be functionalized with reactive peptides 
(i.e. biotin, antibodies) making the whole label larger and 
changing the function and dynamics of the POI [7]. 
The most used labeling strategy to monitor protein 
dynamics is still the fusion of a fluorescent protein to the 
POI. This involves a specific labeling approach by cloning 
the fluorescent tag at the N- or C-terminus of the POI. Most 
of this type of labels come from the original GFP, which is a 
very small protein of about 27 kDa with a 30 Å diameter. 
Today we can use improved GFP variants with different 
physicochemical properties, such as brightness, 
photostability, oligomerization tendency, sensitivity to pH 
variation and maturation rates [8]. For example, certain 
genetic modifications enable the GFP to be photoactivated, 
photoconverted or photoswitched [9-11]. 
The wide range of GFP variants allows us to investigate 
intracellular dynamics such as single protein movement or 
protein interaction kinetics. The fusion of a GFP variant to a 
POI and its detection could unveil intracellular mechanisms 
such as the ability to bind DNA, to migrate through lipid cell 
membranes or the mechanotransduction response [12-14]. 
The classic procedure to internalize the labeled POI into 
cells requires DNA transfection. This involves the 
internalization of a recombinant plasmid coding for the 
labeled POI and detection of the fluorescence after at least 24 
hours. This provides continuous high levels of protein 
expression that could potentially alter the interpretation of 
physiological protein dynamics and kinetics. Other limiting 
aspects of DNA transfection methods are related to the 
dependence of internalization efficiency on the cell type, and 
the long working time required to reach optimal fluorescence 
expression. Direct internalization methods of fluorescent 
POI, such as microinjection and protein transduction, are 
challenging strategies to overcome the technical 
disadvantages of DNA transfection. 
Lawrence and colleagues published a novel genetically 
modified GFP: the supernegative (-30)GFP [15]. Differently 
from the other genetically modified variants, this GFP form 
is optically similar to the original protein but has different 
surface electrostatic characteristics that alter its molecular 
interaction properties [15-16]. From a molecular point of 
view, Lawrence and colleagues replaced 15 surface amino 
acids with negatively charged residues (glutamate and 
aspartate), changing the protein net charge from -7 to -30. 
Zuris and colleagues demonstrated that highly anionic 
proteins can be delivered intracellularly by the same 
electrostatics-driven mechanism used for nucleic acid 
delivery. They exploited the anionic properties of the novel 
GFP to create anionic protein:cationic lipid complexes to 
import intracellularly (-30)GFP-based recombinant proteins 
in vitro and in vivo. To the best of our knowledge, the 
intracellular delivery of proteins able to penetrate the plasma 
membrane –also known as protein transduction – is a 
molecule internalization approach that has not yet been used 
for protein dynamics studies such as nucleocytoplasmic 
transport. In this work, our aim was to engineer a fluorescent 
variant of a transcription factor (TF) suitable for further 
protein localization and intracellular dynamics studies. We 
decided to exploit the advantages offered by the protein 
transduction technology by fusing the (-30)GFP to a 
myogenic TF, MyoD (Myoblast determination protein 1), 
generating a fluorescent variant of MyoD able to be 
delivered into the nucleus as a recombinant protein when 
complexed with cationic lipids. To demonstrate the 
advantages and the suitability of the supernegative TF for 
protein dynamics studies, we assessed the protein 
transduction efficiency and intranuclear localization by 
fluorescence confocal microscopy. We also compared the 
working time and the internalization efficiency for (-30)GFP-
MyoD transduction and classical DNA transfection 
procedures. In addition, we evaluated the influence of the 
supernegative GFP on MyoD transcription promoting 
activity, measuring the gene expression of specific MyoD 
targets by real-time PCR. Finally, we investigated some 
aspects arousing concern about the influence of the (-30)GFP 
on MyoD functionality generating computational models and 
running molecular dynamics simulations. In both gene 
expression analyses and computational simulations, we used 
a photoactivatable variant of MyoD as a functional control 
complex. 
2. Methods 
2.1. Gene cloning. (-30)GFP sequence was amplified 
from pET-(-30)GFP-9xGGS-Cre-6xHis (Addgene, plasmid 
#32372) and subcloned into the prokaryotic vector pRSET A 
using the XbaI and BamHI sites of the vector multiple 
cloning site. The transcription factor MyoD sequence was 
subcloned into the plasmid pRSET A-(-30)GFP using NheI 
and HindIII sites.  
The sequences coding for MyoD, (-30)GFP, (-30)GFP-
MyoD were also inserted into the eukaryotic vector pcDNA 
3 (resistant to kanamycin instead of ampicillin) using NheI 
and HindIII sites, NdeI and NheI sites, NdeI and HindIII 
sites, respectively.  
To generate the plasmid coding for MyoD-PAGFP 
(pMyoD-PAGFP), we subcloned the MyoD sequence into 
the plasmid coding for PAGFP (pPAGFP-N1) (Addgene, 
plasmid #11909) using the BglII and EcorI restriction sites. 
We used TOP10 E. coli strain for gene cloning procedures. 
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2.2. Protein purification. Recombinant variants were 
expressed in the BL21(DE3)pLysS E. coli strain. Starter 
cultures were prepared by growing multiple colonies of E. 
coli cells carrying the recombinant plasmids in a 1L flask 
containing Luria-Bertani medium added with ampicillin and 
chloramphenicol (respectively 100 μg/mL and 33 μg/mL); E. 
coli cells were grown with shaking until they reached an OD 
600nm ~ 0.6, at which time 0.4 mM IPTG was added to 
induce protein expression. Cells expressing recombinant 
proteins were collected after 12 hours of growth with shaking 
at ~17-23 °C. Protein purification required a first step of 
centrifugation at 6500 rpm, 4 °C for 20 minutes. The pellet 
was resuspended in lysis buffer (PBS-NaCl 2M). Cells were 
disrupted by sonication on ice, using a Branson Sonifier 450 
(Branson Ultrasonics, Danbury, CT, USA). The lysate was 
cleared by centrifuging at 12500 rpm, 4 °C for 30 minutes. 
The recombinant proteins were recovered from supernatant 
by chromatography using a HIS-Select® Nickel Affinity Gel 
(Sigma-Aldrich). After separation on the chromatographic 
column, the proteins were eluted (NaCl 2M, Imidazol 0.75M, 
pH 8) and dialyzed (NaCl 0.5M, PBS). Elution products 
were analyzed by spectrophotofluorometer to check the 
quality and quantity of the purified proteins. 
2.3. Cell culture. Rat bone marrow mesenchymal stem cells 
(rBM-MSCs) were kindly provided by Dr. Barbara 
Bonandrini (Dept. of Bionengineering, Mario Negri Institute 
for Pharmacological Research, Bergamo, Italy) [17]. Cells 
were cultured using α-MEM supplemented with 20% fetal 
bovine serum (v/v) (Gibco, Thermo Fisher Scientific), 
penicillin 100 IU/mL/ streptomycin 100 µg/mL (Invitrogen, 
Thermo Fisher Scientific) and 0.5 mM L-glutamine 
(Invitrogen, Thermo Fisher Scientific). Cells were seeded in 
a six-well plate at a density of 35x103 cells/well for genetic 
assays. For fluorescence imaging analyses cells were seeded 
either in a 24-well plate at 8.5x103 cells/well or into 8-well 
Nunc® Lab-Tek® at 5x103 cells/well.  
2.4. Protein Transduction. 24 hours before transduction, 
cells were plated into a 24-well plate to reach 50% 
confluency. For transduction of (-30)GFP-MyoD we tested 
four transfection reagents, liposome-based and non-
liposomal: Lipofectamine™ MessengerMAX, 
Lipofectamine™ 3000, JetPRIME®, Fugene® HD. We set 
specific conditions starting from the manufacturer’s 
instructions (see Supplementary Table 1). One hour before 
addition of the anionic protein:cationic molecule complex, 
we conditioned the cell culture with serum-free Optimem 
medium (Gibco, Thermo Fisher Scientific). Three hours after 
protein transduction we replaced the transduction medium 
with cell growth medium. 
2.5 DNA transfection. DNA vectors were transfected using 
FuGENE® HD transfection reagent (Promega Corporation) 
according to the manufacturer’s instructions. Cells were 
plated 24 hours before transfection into a six-well plate at a 
density of 35x103 cells/well. We selected 
3:1=FuGENE:DNA as the optimal transfection ratio. 
2.5 Transduction\transfection efficiency. To assess the 
transduction or transfection efficiency of our constructs, we 
incubated cells in growth medium supplemented with 
Hoechst 33342 (1µg/ml) (Thermo Fisher Scientific, USA). 
After 10 minutes cells were fixed with 4% paraformaldheyde 
(PAF) for 15 minutes, washed with PBS, then mounted on a 
glass slide. Transduction or transfection efficiency was 
measured 4 hours from protein addition or 48 hours from 
DNA transfection, and was calculated as:  
Efficiency (%) = (transduced cells)/(total amount of nuclei) 
Cells were considered transduced or transfected when at least 
one green fluorescent spot was detected.  
2.6 Fluorescence microscopy and image analysis. Cell 
fluorescence was detected using a FluoView FV10i confocal 
laser scanning microscope (Olympus, Japan) equipped with 
405 nm and 473 nm laser diodes for GFP and PAGFP 
acquisition and a water-immersion 60X phase contrast 
objective/NA 1.2. Live cell imaging was done at 37 °C, 5% 
CO2. Fixed cell imaging was done at room temperature. The 
following collection ranges were adopted: 352-455 nm 
(Hoechst 33342), 489–550 nm ((-30)GFP and PAGFP). 
Images were analysed with ImageJ software. 
2.7 Photoactivation. Protein photoactivation was done by 
fluorescence confocal microscopy (FluoView FV10i, 
Olympus, Japan). Photoactivation of MyoD-PAGFP was 
done by single cell irradiation with a 405 nm light laser 
enhancing the green light fluorescence emission. 
Photoactivated cells were visible by exciting them with 10% 
of the 473nm laser power and acquiring the emission spectra 
in the same range as for (-30)GFP. 
2.8 Gene expression. To measure the expression levels of 
mRNA target genes of MyoD, MSCs were treated into a six-
well plate at a density of 35x103 cells/well. Following the 
literature [18], in the case of protein transduction, we 
extracted total mRNA nine hours after protein addition, thus 
six hours after optimal protein nuclear detection (activated 
state). In the case of DNA transfection, MSC culture samples 
were lysed for RNA extraction after 72 hours. RNA was 
extracted from the MSC culture samples using a miRNeasy 
Mini Kit (Qiazol™) following the manufacturer’s 
instructions. The quantity and purity of extracted RNA was 
measured by spectrophotometry (ND-1000; NanoDrop™). 
cDNA was synthesized from total RNA using the High-
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Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems™). We measured relative mRNA expression 
levels of myogenin (Myog), cadherin 15 (Cdh15), desmin 
(Des), Creatin Kinase M-Type (CKM) by quantitative real-
time polymerase chain reaction (qRT-PCR) using TaqMan™ 
Reagents (Applied Biosystems, Thermo Fisher Scientific) on 
a 7900HT Fast Real-Time PCR System (Applied 
Biosystems, Thermo Fisher Scientific). We used 18s rRNA 
as reference gene. To measure the gene expression level, we 
employed the widely used Livak method, which calculates 
the normalized expression ratio respect to a negative control, 
the calibrator. 
pMyoD was used as experimental positive control. As 
calibrator for pMyoD, we used a plasmid coding for a control 
protein with a similar size but with no regulatory function, 
such as transcriptional activity. We chose a commonly used 
enhanced form of GFP (pEGFP). 
2.9 Molecular Models. The 3D models of (-30)GFP and 
PAGFP were obtained by homology modeling starting from 
the photoactivatable GFP deposited in the RCSB Protein 
Data Bank (PDB code: 3GJ2). For alignment we used the 
NCBI-BLASTp tool, available on the NCBI website. 3D 
models for (-30)GFP and PAGFP were examined by surface 
electrostatic potential analyses using the APBS plugin of 
Visual Molecular Dynamics (VMD) software [19]. We took 
the atomic structure of MyoD BHLH domain (DNA-binding 
domain) from the model 1MDY in RCSB PDB, which is a 
homo-dimer bound to the DNA consensus sequence. We 
extracted the chain in yellow in Supplementary Figure 1A 
corresponding to the BHLH binding domain of a MyoD 
monomer and used this monomer to build the GFP-MyoD 
molecular complexes. To evaluate the influence of the 
lacking MyoD region, not available in PDB, we predicted the 
protein structure of the whole protein using PSI-blast based 
secondary structure PREDiction (PSIPRED v3.3) and 
DISOrder PREDiction (DISOPRED3) servers [20-21]. 
2.10 MD configurations. After minimization and 
preliminary equilibration, the 3D structures of (-30)GFP and 
PAGFP were used in combination with the MyoD model to 
obtain GFP-MyoD complexes. Four configurations of each 
GFP-MyoD molecular complex were defined with different 
positions and orientations of the MyoD BHLH domain with 
respect to the GFP. To generate the 4 configurations, the 
center of mass of the GFP was assumed as the origin of the 
axes of the molecular system (XGFP, YGFP, ZGFP=0, 0, 0). 
Then, in relation to the specific GFP, the MyoD domain was 
rigidly moved obtaining the following configurations: 
Configuration n° 1: (XM, YM, ZM= +3, +10, -30) 
 Configuration n° 2: (XM, YM, ZM= +28, +15, 5) 
 Configuration n° 3: (XM, YM, ZM= 0, +15, +28) 
 Configuration n° 4: (XM, YM, ZM= -27, +10, +5) 
where XM, YM, ZM are coordinates of the MyoD domain (see 
Supplementary Figure 1E). 
2.11 MD simulation parameters. MD simulations were 
carried out with NAnoscale Molecular Dynamics 2.12 
(NAMD) software together with the VMD software [19, 22]. 
The Force Field used was CHARMM 36 and all the MD 
simulations were done in explicit TIP3 water molecules, 
applying periodic boundary conditions. 
(-30)GFP and PAGFP were first equilibrated for 1ns 
under constant pressure and temperature (NPT ensemble) to 
relax the volume of the periodic boundary box. The 
equilibrated structures of GFPs were then used to build the 
GFP-MyoD complexes in the four configurations (see MD 
configurations set-up). To relax the volume of the periodic 
boundary box, the MD simulations were carried out under 
NPT conditions. The pressure was set at 1 atm, the 
temperature at 310 K, the time step was 2 fs and the non-
bonded cut-off was 12 Ȧ. Langevin dynamics were 
employed to control the temperature, maintaining the 
pressure at 1 atm, a period of 100 ns and a decay of 50 fs. 
Trajectories were recorded every 500 fs for 2,500,000 steps 
with 5 ns. 
2.12 Non-bonded interaction energies. Non-bonded 
interaction energies were calculated with the NAMDEnergy 
plugin. First, we recorded the Van der Waals energy, 
electrostatic Coulomb energy and the total non-bonded 
interaction energy between the MyoD BHLH domain and the 
specific GFP. Then we examined the non-bonded interaction 
energies of each fluorescent protein with the BHLH domain 
separated in three elements: Helix 1 (residues from 105 to 
136); Loop (residues from 137 to 146); Helix 2 (residues 
from 147 to 166). The energies were expressed in kcal/mol. 
2.13 Statistical analyses. Experiments were performed in 
triplicate and the data were analysed by one-way analysis of 
variance (ANOVA), two-way ANOVA and post hoc tests, or 
with Student’s t-test for direct comparison of two groups. 
Associations with P < 0.05 were considered significant. ns P 
>0.05; * P <0.05; ** P <0.01; *** P <0.001; **** P <0.0001. 
3. Results 
3.1 (-30)GFP-MyoD transduction and nuclear 
localization.  
To achieve the best (-30)GFP-MyoD transduction 
efficiency, we tested four cationic reagents generally used for 
DNA o RNA transfection: two lipid-based, Lipofectamine™ 
3000 and Lipofectamine™ MessengerMAX, and two non-
liposomal, Fugene® HD and JetPRIME® PolyPlus. We 
achieved optimal fluorescence detection 3-4 hours after 
addition of the transduction complex. Then we assessed the 
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intracellular (-30)GFP-MyoD delivery by fluorescence 
confocal microscopy. Most of the recombinant protein 
efficiently reached the nucleus, where the TF is active and 
physiologically localized (Figure 1A). These results 
indicated that the (-30)GFP did not alter the localization of 
the native TF MyoD, facilitating the passage of both the cell 
membrane and the nuclear envelope. We calculated the 
protein transduction efficiency as the ratio of transduced cells 
to the total amount of MSC nuclei stained with Hoechst 
33342 dye. The best (-30)GFP-MyoD transduction efficiency 
was reached by the complexation with both Lipofectamine™ 
MessengerMAX and JetPRIME® Polylus (Figure 1B). The 
two reagents showed comparable transduction efficiency but, 
as shown in Figure 1A, complexation with JetPRIME® 
Polyplus generated a large amount of protein aggregates that 
could interfere with fluorescence confocal microscopy 
acquisitions and measurements. We therefore selected 
Lipofectamines™ MessengerMAX as the best cationic lipid-
based transfection reagent for intracellular (-30)GFP-MyoD 
delivery. 
Finally, we compared the efficiency of (-30)GFP-MyoD 
transduction with the transfection of a plasmid coding for a 
control fluorescent protein (pmaxGFP): efficiency was 5 
times greater in the protein transduction-based internalization 
(Figure 1C). The (-30)GFP-based transduction thus offers the 
possibility of intracellular detection of the POI after a few 
hours and with greater efficiency than the standard DNA 
transfection. 
 
Figure 1. (-30)GFP-MyoD transduction efficiency. (A) Confocal images of MSCs transduced with (-30)GFP-MyoD when 
complexed with Lipofectamine™ MessengerMax (Lipo MMax), Lipofectamines™ 3000 (Lipo 3000), JetPRIME® Polyplus 
or Fugene® HD. Transduced cells are highlighted by the white arrows. The same images are shown superimposed on 
Hoechst33342 dye nuclear stain (lower images). Scale bar 20 μm; (B) Graphical representation of (-30)GFP-MyoD 
transduction efficiency using different cationic transfection reagents. Data were analyzed by one-way ANOVA test using 
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Tukey’s test for multiple comparisons; for each replicate we counted 85 cells. (C) Comparison of (-30)GFP-MyoD 
transduction and standard transfection of a plasmid coding for a control fluorescent protein (pmaxGFP). Data were analyzed 
by Student’s t-test. For each replicate we counted 85 cells. Data are shown as mean ± SD. 
3.1 (-30)GFP inhibits MyoD transcription promoting 
activity.  
To further investigate the properties of the recombinant 
fluorescent tool and the influence of the supernegative GFP 
on MyoD, we examined its function measuring its 
transcription promoting activity by real-time PCR. We 
measured the mRNA expression levels of four target genes 
of MyoD: myogenin (Myog), creatine kinase M-type (CKM), 
desmin and cadherin 15 (Cdh15). We extracted the total 
mRNA in MSCs overexpressing the native MyoD at four 
time points (24h, 48h, 72h, 96h) and measured the target 
genes expression. Among the analysed target genes, Myog 
and CKM were expressed at higher levels than the 
untransfected MSCs at 72 hours (difference >90%). Thus, we 
selected these as the optimal genes to be analysed in order to 
evaluate the MyoD transcription promoting activity (see 
Supplementary Figure 2). 
To analyze (-30)GFP-MyoD function, we transduced 
MSCs with the supernegative TF complexed with 
Lipofectamine™ MessengerMax. We compared the 
transcription promoting activity of (-30)GFP-MyoD with the 
function of MyoD without (-30)GFP. We used MSCs 
transiently transfected with the plasmid coding for the native 
MyoD (pMyoD) as experimental positive control. Figure 2A 
and B show the resulting mRNA expression levels of Myog 
and CKM. In both cases (-30)GFP-MyoD did not promote 
the transcription of any gene suggesting an inhibitory effect 
of the (-30)GFP on MyoD activity. To exclude any problems 
related to protein manipulation methods, we transfected 
MSCs with a eukaryotic plasmid coding for the 
supernegative variant of MyoD and measured the mRNA 
expression levels 72 hours after transfection. The results 
confirmed the inhibitory effect of the (-30)GFP on MyoD 
(Figure 2C and D). 
To check that the inhibitory effect was (-30)GFP-
dependent, we fused MyoD to another GFP-based probe. We 
chose the photoactivatable GFP (PAGFP), a GFP variant that 
emits green fluorescence after photo-irradiation at 405 nm. 
Differently from the (-30)GFP, PAGFP cannot complex with 
cationic lipids and pass the plasma membrane. Thus, we 
obtained MSCs overexpressing the photoactivatable variant 
of MyoD by a standard DNA transfection procedure. We 
evaluated the quality of the fluorescent recombinant TF and 
assessed the maintenance of the physiological nuclear 
localization 48 hours after DNA transfection (Figure 3A). 
We extracted the total RNA 72 hours after DNA transfection 
and measured its transcription promoting activity. The 
MyoD-PAGFP significantly promoted Myog and CKM 
transcription compared to PAGFP without MyoD (Figure 3B 
and C). Even though at lower levels than the native TF 
(pMyoD), the activity of the photoactivatable MyoD 
confirmed that MyoD is suitable for engineering with 
fluorescent probes and that the inhibitory effect is specific to 
(-30)GFP. 
 Figure 2. Graphical representation of (-30)GFP-MyoD transcription promoting activity. (A-B) (-30)GFP-MyoD represents 
MSCs transduced with the recombinant (-30)GFP-MyoD while pMyoD is the positive control, representing MSCs transfected 
with the plasmid coding for MyoD; (C-D) p(-30)GFP-MyoD shows the mRNA expression levels of MSCs transfected with a 
plasmid coding for (-30)GFP-MyoD. The experimental group including the calibrators was analysed by one-way ANOVA 
and Student’s t-test was used to compare the experimental-paired groups. Data are mean ± SD. Significance symbols 
highlighted in red refer to the comparison of each group and its calibrator. Significance symbols in black refer to one-way 
ANOVA. 
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Figure 3. Transcription promoting activity of MyoD fused to PAGFP. (A) Confocal images of MSCs transfected with 
pMyoD-PAGFP. The left acquisition shows the pre-activated state of the photoactivatable variant of MyoD and the right 
image shows the fluorescent state after photo-irradiation at 405 nm; (B-C) graphical representation of Myog and CKM 
mRNA expression levels in MSCs transfected with the plasmids coding for MyoD or MyoD-PAGFP. The experimental 
group including the calibrators was analysed by one-way ANOVA and Student’s t-test was used to compare the two 
experimental-paired groups. Data are mean ± SD. Significance symbols highlighted in red refer to the comparison of each 
group and its calibrator. Significance symbols in black refer to one-way ANOVA. 
 
3.2 Unraveling the inhibitory effects of (-30)GFP via 
molecular dynamics.  
We hypothesized that the (-30)GFP inhibitory effect on 
MyoD transcription promoting activity might be due to the 
interaction between the peculiar surface negative charges of 
the (-30)GFP, exposing a large number of negative charges, 
and the positive charges characterizing the DNA binding 
domain of the TF, thus interfering with MyoD function. To 
verify this, we used molecular dynamics as a suitable 
computational approach for further investigation at the 
atomistic level. We generated two molecular models, one 
characterized by a MyoD BHLH domain (DNA binding 
domain) and (-30)GFP and the second consisting of a MyoD 
BHLH domain and PAGFP. Since MyoD-PAGFP was the 
fluorescent variant of MyoD that experimentally showed 
positive transcription promoting activity, the second 
computational model was used as control. We examined 
molecular dynamics trajectories by analyzing structural 
rearrangements and stability and non-bonded interaction 
energies between MyoD BHLH domain and the GFPs. 
3.2.1 GFP and MyoD structural features. The 3D 
structures of the experimentally used (-30)GFP and PAGFP 
were obtained aligning the sequences to the amino acid 
sequence of the PAGFP deposited in the Protein Data Bank 
(PDB code 3GJ2). Since the sequence alignments revealed 
close identity in both cases (97% identity for PAGFP and 
91% for (-30)GFP), we used the 3GJ2 structure as template 
for 3D homology modeling. Surface electrostatic potential 
analysis of the GFP molecular models showed a (-30)GFP 
surface charge of -28, close to the theoretical value of -30, 
and a weak negative charge of -6 for the PAGFP surface, 
CB
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biochemically similar to the standard GFP used by Lawrence 
and colleagues (-7) to generate the supernegative GFP [15]. 
The molecular model of the MyoD DNA binding domain 
was generated starting from the 1MDY.pdb available in the 
Protein Data Bank, which is a homo-dimer of the MyoD 
BHLH domain-DNA complex (see Supplementary Figure 
1A). We extracted the monomeric domain of MyoD and 
analyzed the residues in the dimerization domain (see 
Supplementary Figure 1B) and DNA binding domain (see 
Supplementary Figure 1C). The residues involved in 
dimerization were mainly hydrophobic while amino acids 
that interact with DNA were mainly positively charged and 
belong for the most to the basic region (108-125aa) (see 
Supplementary Figure 1D). 
The complete structure of MyoD has not yet been 
crystallized and solved by X-ray diffraction, so the 3D model 
of the entire structure is not available. Using the protein 
structure prediction servers PSI-blast-based secondary 
structure PREDiction (PSIPRED v3.3) and DISOrder 
PREdiction (DISOPRED3), we verified that the global 
structure of MyoD was predominantly disordered, except for 
the BHLH domain (data not shown). 
We then generated two molecular models characterizing 
the (-30)GFP-MyoD and PAGFP-MyoD complexes. Since 
MyoD was characterized by the only structured functional 
core of the protein (BHLH domain), we created four complex 
configurations facing the MyoD domain in different 
positions in relation to the GFPs (see Supplementary Figure 
1E). For each configuration we analyzed structural 
rearrangements pre- and post-simulation and structural 
stability by root mean square deviation (RMSD) calculation 
of trajectories and the features of the binding regions 
occurred between MyoD and related GFP. We also evaluated 
non-bonded interaction energies to quantify the interaction 
between the MyoD BHLH domain and the specific GFP. 
3.2.2 Interaction sites and key residues. We analyzed 
each configuration, observing the complexes rearrangements 
in pre- and post-simulation conformation and the residues 
involved in contact regions between each GFP and the MyoD 
BHLH domain. Figure 4 shows the intermolecular contacts at 
the end of the MD simulation run of the first configuration of 
the MyoD-GFP complexes. The first noteworthy finding is 
that the monomer moved differently depending on the type 
of GFP in the system. In fact, as shown in the insets of 
Figure 4 the MyoD BHLH monomer moved perpendicularly 
with respect to the PAGFP (Figure 4A) but remained 
longitudinal and in proximity to the GFP molecule in the 
case of (-30)GFP (Figure 4B and C). As highlighted in 
Figure 4A and B both GFPs kept contact with the loop of 
MyoD, involving residues with different chemical 
characteristics (hydrophobic, polar and charged). Only (-
30)GFP showed specific non-bonded interactions with the 
MyoD BHLH basic region (Figure 4C). The interactions 
involved the MyoD positively charged Arg111, the (-30)GFP 
negative Glu170 and the (-30)GFP charge-neutral Gln169. 
As highlighted in Supplementary Figure 1C, Arg111 is a key 
residue of the BHLH domain involved in the DNA binding. 
Except for the second configuration, in which the monomer 
moved around the GFPs without generating particular non-
bonded interactions, the third and the fourth configurations 
confirmed what was seen in the first configuration. The 
residues of the MyoD DNA binding region involved in the 
interaction with the (-30)GFP of the third and the fourth 
configurations are Arg 110, Arg 111 and Arg 110, Arg 117, 
Arg 120, respectively.  
 
 
Figure 4. VMD representation of residues involved in 
intermolecular contacts between the fluorescent protein and 
MyoD after MD simulation of the first configuration. The 
square inside the insets on the right represents the region of 
the molecular model detailed on the left. PAGFP is 
represented in iceblue, (-30)GFP in green and the MyoD 
domain in yellow. PAGFP interacted with the MyoD domain 
at the loop region (A). (-30)GFP interacted with the MyoD 
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domain at both the loop region (B) and the DNA-binding 
region (C). 
 
Table 1. Summary of structural analyses. X indicates when the specific MyoD region interacted with the (-30)GFP or 
PAGFP and if the contacts were charge-driven or not. RMSD values are mean ± SD and are calculated from last 500ps 
simulation. 
  
  INTERACTIONS RMSD 
CONFIG. COMPLEX 
DNA binding 
domain  
(Helix 1) 
Loop 
Dimerization 
domain  
(Helix 2) 
Charge-driven  (last 500ps) 
1
st
  
PAGFP-MyoD  X   8.08 ±1.88 
(-30)GFP-MyoD X  X   X 2.77 ± 0.42 
2
nd
  
PAGFP-MyoD  X    6.28 ± 0.49 
(-30)GFP-MyoD         9.94 ±0.53 
3
rd
  
PAGFP-MyoD  X     3.68 ±0.49 
(-30)GFP-MyoD  X   X  X 2.68 ±0.24 
4
th
  
PAGFP-MyoD X      7.10 ±0.67 
(-30)GFP-MyoD X    X 4.71 ±0.29 
 
3.2.3 GFP-MyoD non-bonded interaction energies. To 
quantify the charge-based attractive effect observed in 
structural analyses, we examined the non-bonded interaction 
energies of the molecular complexes. First we measured Van 
der Waals and electrostatic energies between the MyoD 
BHLH domain and their related GFP. The sum of the two 
values was considered the total non-bonded interaction 
energies. All the calculated energy values are reported in 
Supplementary Table 2. Figure 5A (and Supplementary 
Figure 3A) described the mean energy values (Van der 
Waals and electrostatic energy) of the last (and first) 500 ps 
of the MD simulation run. As shown in Figure 5A, in each of 
the four explored configurations, the interaction energies 
were negative and significantly lower in the MyoD domain 
and (-30)GFP than in MyoD and PAGFP. Considering that 
lower negative values for non-bonded interaction energies 
mean a greater attraction effect, these values confirmed that 
the MyoD domain interacted more strongly with the 
supernegative GFP than with the PAGFP. Analyzing the 
electrostatic energy contribution (blue segment) expressed by 
the percentage in the graph, in relation to Van der Waals 
contribution (orange segment), the charge-based interaction 
always contributed more in the case of (-30)GFP-MyoD 
complex. This supported the hypothesis that (-30)GFP has a 
strong interaction with MyoD mediated by charge-driven 
attractive contacts. 
To understand better which part of the MyoD BHLH 
domain was involved in the charge-based contact with the (-
30)GFP, we measured the non-bonded interaction energies 
separating the BHLH domain in the three main characteristic 
elements: Helix 1 (from residues 105-136), Helix 2 (from 
residues 147-166) and Loop (residues 137-146). As shown in 
Figure 5B (and Supplementary Figure 3B for the first 500 
ps), the MyoD characteristic element that contributed most to 
the interaction energy values was Helix 1, and thus the DNA 
binding region, confirming the structural analyses. 
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Figure 5. Comparison of interaction energies extracted from 
the last 500 picoseconds simulation. (A) The non-bonded 
interaction energy (electrostatic contribution in blue and Van 
der Waals contribution in orange) is calculated for the MyoD 
BHLH domain and the specific GFP. The percentage 
indicates the contribution of electrostatic energy to the total 
non-bonded energies. Groups were analyzed by two-way 
ANOVA followed by Sidak’s multiple comparisons test. 
Data are mean ±SD. (B) Distribution of the non-bonded 
interaction energies calculated for the GFPs and the three 
characteristic elements of the MyoD BHLH domain. Helix 1 
(DNA binding domain, residues 105-136); Helix 2 
(dimerization domain, residues 147-166); Loop (residues 
137-146). The energies were extracted from the last 500 ps 
simulation. Data are mean and the sum of the energies of the 
three elements gives the total non-bonded interaction 
energies between the BHLH domain and the specific GFP. 
4. Discussion 
The standard procedure used to detect a POI fused to a 
GFP-based fluorescent probe requires the transfection of a 
coding DNA plasmid and its expression by eukaryotic cells. 
Protein transduction is an alternative to DNA transfection to 
internalize a purified protein and accelerate the fluorescence 
detection time up to 10-fold. Thanks to its surface 
electrostatic characteristics, (-30)GFP can be cell internalized 
in a few hours and can be considered a good candidate for 
protein internalization. Despite the characteristics and 
advantages of protein transduction, featuring a reduced time 
for intracellular protein delivery and the control of cell 
loaded molecules, this internalization method has not yet 
been exploited to study intracellular protein tracking. With 
this purpose and considering (-30)GFP features, we 
developed a supernegative fluorescent variant of MyoD able 
to penetrate the plasma membrane when complexed with 
cationic molecules. We observed that the (-30)GFP-MyoD 
transduced in MSCs reached the nucleus in a few hours, with 
high transduction efficiency, significantly higher than 
standard DNA transfection methods. The working time 
required for (-30)GFP-MyoD transduction was comparable 
to other expertise-requiring protein internalization 
techniques, such as microinjection [23]. Moreover, our 
results are in line with the report by Zuris and colleagues in 
which they fused the (-30)GFP to different proteins and 
observed intracellular protein delivery both in vitro and in 
vivo. As Zuris demonstrated, the most efficient anionic 
protein:cationic lipid complex was based on the use of 
lipofectamines designed for RNA transfection [16]. Our data 
confirmed that the cationic reagent that was more efficient in 
complexing the (-30)GFP-MyoD was Lipofectamine™ 
MessengerMAX, which is specifically designed for mRNA 
intracellular delivery. 
With a view to use this fluorescent labeling method to 
study rapid intracellular mechanisms, such as 
mechanotransduction events or protein-protein and protein-
DNA interactions, we demonstrated that this (-30)GFP-based 
strategy considerably improves the measurement procedures 
by increasing the number of cells containing the fluorescent 
POI and reducing the experimental time. In fact, compared to 
standard GFP-based approaches, that require at least two 
working days for measurements, we were able to transduce 
MSCs and potentially measure protein dynamics the same 
day (3 hours after protein transduction). As mentioned above, 
mechanotransduction is an example of rapid intracellular 
events since cells react to mechanical stimuli in a time-
dependent way [24-28]. The (-30)GFP-based strategy could 
be useful to shorten the technical delay so as to measure the 
mechanotransduction event in a quick time after the 
mechanical input. For instance, the (-30)GFP-MyoD could 
be used to transduce mechanically stimulated cells and study 
intracellular dynamics, such as nucleocytoplasmic shuttling 
and nuclear permeability in response to mechanical stimuli. 
This approach could avoid the loss of fundamental 
information or unclear evaluation of the phenomenon. 
To further clarify the functional properties of the 
supernegative recombinant factor, we analyzed the 
transcription promoting activity by real-time PCR. 
Unexpectedly, gene expression results showed an inhibitory 
effect of the (-30)GFP on the MyoD transcription promoting 
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activity. Unlike the proteins fused to the (-30)GFP by Zuris 
and colleagues (Cas9, CRE and TALE-VP64), MyoD is a TF 
that can bind DNA with a specific BHLH domain 
characterized by a positively charged region. Our hypothesis 
was that the specific inhibitory effect of the (-30)GFP on the 
transcription promoting activity of MyoD was related to the 
charge-guided interference between the positive charges of 
the MyoD BHLH domain and the peculiar negatively 
charged surface of the supernegative GFP. To verify this, we 
used MD simulations to compare the (-30)GFP-MyoD 
BHLH domain complex with the PAGFP-MyoD complex; 
experimentally this produced a functional recombinant 
factor. Computational analyses confirmed that the MyoD 
domain is attracted and stabilized more by (-30)GFP than 
PAGFP through charge-driven interactions. This suggested 
an improper stabilization of MyoD in the presence of the (-
30)GFP. Furthermore, the structural element that evidently 
gave the main contribution to the intermolecular interactions 
was the basic region of the MyoD domain, which is involved 
in the DNA binding. We therefore inferred that improper 
stabilization at the DNA binding region might alter its 
function by avoiding the DNA consensus sequence binding 
or the correct promotion of the transcriptional machinery’s 
activity. Although the dimerization domain was not found to 
be negatively influenced by the supernegative GFP, the 
improper stabilization of the DNA binding region would not 
exclude an additional contribution due to a possible 
interference in the formation of the (-30)GFP-MyoD dimer 
necessary for the MyoD transcription promoting. 
In light of the computational observations and 
experimental evidences, the DNA binding domain appears 
crucial for the transcriptional promoting activity of (-
30)GFP-based factors. In the perspective of finding suitable 
differentiation TFs to be labeled with the (-30)GFP, it could 
be interesting to consider proteins with DNA-binding 
domains structurally different from the BHLH region. So far, 
the only (-30)GFP labeled proteins that resulted functionally 
active (Cas9, CRE recombinase and TALE-VP64), are 
characterized by peculiar and specific DNA-interacting 
regions, not commonly present in differentiation TFs [16]. 
For example, among the mesenchymal stem cell 
differentiation factors, two common DNA-binding domains, 
structurally different from the BHLH region, are the basic 
leucine zipper and the zinc finger domain [29]. In this 
respect, two factors that could represent good candidates for 
further development are the adipogenic CAAT/enhancer 
binding proteins (c/EBPs) and the osteogenic TF Osterix. 
To reduce the inhibitory effect of the (-30)GFP on MyoD, 
different strategies are possible. Focusing on the surface 
electrostatic characteristics of the supernegative label, it 
could be interesting to engineer a GFP negative enough to 
complex with cationic lipids and sufficiently charge-inert not 
to interfere with transcription promoting activity. Actually, 
Zuris and colleagues already proposed other polyanionic 
GFP variants with a lower net theoretical charge (−20 or -7). 
Both were able to promote cationic lipid-mediated delivery 
of a POI but in a charge-dependent manner and thus, at a 
lower efficiency respect to the (-30)GFP [16]. Therefore, we 
should optimize this strategy to achieve the best compromise 
between delivery efficiency and functionality influence. To 
this respect, to counteract the lower negative charge, an 
additional possibility may be to test or develop different 
cationic lipid nanocarrier systems with an increased net 
positive charge or enhanced cell membrane transducing 
efficiency [30]. 
Another alternative strategy to diminish the inhibitory 
effect could be to change the distribution of the 30 negative 
charges on the protein surface without reducing them. 
Following this idea, we should change the original modified 
residues of the starting GFP, so that the final protein would 
have a global net surface charge of -30 but with a different 
charge distribution and, thus potentially different MyoD-
BHLH domain interaction dynamics. To this end, further 
MD studies may be useful for selecting the best negative 
charge distribution. 
From the view point of finding a negative GFP that could 
be used as a label for both protein dynamics and activity-
based investigations, we could screen different supernegative 
GFP using MD simulations to evaluate the influence of the 
GFP on MyoD activity and then doing experimental 
investigations to validate the computational results.  
5. Conclusions 
In conclusion, we have demonstrated that the supernegative 
GFP offers an efficient strategy for protein intracellular 
tracking studies. Although its inhibitory effect on MyoD 
activity could limit further functionality-based applications, 
the fluorescent tool does not interfere with the physiological 
localization of the fused POI and, in comparison to classical 
procedures, it markedly reduces the time needed for its 
detection, increasing the protein delivery efficiency. These 
properties make it suitable for clarifying several molecular 
mechanisms of unclear complex intracellular events. 
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